Skip to main content
Premium Trial:

Request an Annual Quote

Joel McComb, Gregory Heath, Stephen Becker, Beth Ladin

Premium
Joel McComb has become senior vice president and general manager of Illumina’s life sciences business unit, and Gregory Heath has become senior vice president and general manager of the company’s diagnostics business unit, Illumina said this week.
 
McComb joins Illumina from GE Healthcare, where he held a number of executive positions, most recently president of the interventional medicine business. Prior to this role, he was president of life sciences discovery systems, a business unit that was formed after GE acquired Amersham Biosciences. McComb holds a BS in genetics from the University of California, Davis, and an MBA from the Golden Gate University in San Francisco. In his new position at Illumina, he is responsible for managing all products and services related to the research market, namely the BeadArray, BeadXpress, and sequencing product lines.
 
Heath comes to Illumina from Roche Molecular Systems, where he held a number of senior executive positions, including head of clinical genomics, senior vice president of global product marketing, senior vice president of global marketing and business development, and, most recently, senior vice president of global business. Heath holds a PhD in experimental psychology from Virginia Commonwealth University, an MA in experimental psychology from Hollins College, and a BS in psychology from Illinois State University. At Illumina, he is responsible for managing the emerging diagnostics business, specifically overseeing the development of diagnostic content for the BeadXpress system, and ultimately for Illumina's sequencing products.
 

 
Stephen Becker has become vice president and commercial officer of RainDance Technologies, the company said this week. He joins RainDance from Agilent Technologies, where he was senior sales manager in the company's Americas field operations. Prior to that, he held several senior management positions at GE Healthcare, formerly Amersham Pharmacia Biotech. Becker has a bachelor's degree in biology from St. Mary's College of California.
 

 
Beth Ladin has become vice president of operations at NuGen Technologies, the company said this week. Prior to NuGen, she held several positions at Applied Biosystems, where she most recently was senior director of scientific operations for the applied markets division.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.